TJHA
ALNY icon

Thomas J. Herzfeld Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Thomas J. Herzfeld Advisors’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-21
Closed -$3.72K – 163
2023
Q3 		$3.72K Hold
21
– – ﹤0.01% 283
2023
Q2 		$3.99K Hold
21
– – ﹤0.01% 279
2023
Q1 		$4.21K Hold
21
– – ﹤0.01% 254
2022
Q4 		$4.99K Buy
21
+7
+50% +$1.49K ﹤0.01% 234
2022
Q3 		$3K Buy
+14
New +$2.67K ﹤0.01% 239
2016
Q1 		– Sell
-50
Closed -$5K – 333
2015
Q4 		$5K Hold
50
– – ﹤0.01% 313
2015
Q3 		$4K Buy
+50
New +$5.55K ﹤0.01% 315

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return